TM4SF1 promoted epithelial–mesenchymal transition (EMT) and cancer stemness via the Wnt/β-catenin/SOX2 pathway in CRC, which revealed that TM4SF1 modulated SOX2 expression in a Wnt/β-catenin activation-dependent manner [129]. The gene discussed is TM4SF1; the disease is cancer.